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Psychiatric Disorders Induced by Twiddler’s Syndrome May
Pose Treatment Challenges in Clinical Practice
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ABSTRACT
Twiddler’s syndrome is a rare condition caused by the coiling of the leads, leading to
a malfunction in the pacemaker or automated implantable cardioverter-defibrillator
(AICD). Bayliss first described it in 1968 as a rare but potentially fatal complication of
pacemaker treatment.1 Inappropriate shocks due to malfunctioning of the AICD can be
devastating, traumatic, or fatal to the patient.
Traumatic and inappropriate shocks can cause patients to develop stress or anxiety
disorders associated with their AICD. Treatment for anxiety or acute stress disorder with
medications can be difficult due to a patient’s underlying proarrhythmic conditions.
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We are presenting a case report regarding a malfunctioning AICD that caused the
patient to develop an acute stress disorder with worsening of her underlying anxiety
disorder and the challenges posed by treating her.
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INTRODUCTION
Twiddler’s syndrome has an estimated frequency
of 0.07%.2 It usually occurs in the first year of
implantation but can occur later.3 Unintentional or
deliberate manipulation of the generator within the
skin pocket of the patient will result in the coiling of
generator leads.3 It is dangerous in patients with a
defibrillator because of the loss of adequate sensing
of the lead and capturing of the rhythm and possible
false treatment of malignant ventricular arrhythmias.3
Risk factors include obesity or elderly patients
because of the loose subcutaneous tissue allowing
the pulse generator to rotate in its pocket. Other
risk factors include female gender, weight loss,
exaggerated upper limb movements, device
manipulation, or a large pocket size relative to the
defibrillator.4
Patients with Twiddler’s syndrome should be
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admitted to a telemetry bed for monitoring prior
to surgical intervention.5 Creating a small surgical
pocket and suturing the device to the fascia can help
prevent manipulation of the pulse generator and
lead displacement.6 Patient education and counseling
against further manipulation are important for longterm management.3
We present a case report regarding a malfunctioning
AICD that caused the patient to develop an acute
stress disorder with worsening of her underlying
anxiety disorder and the challenges posed by treating
her.
CASE REPORT
A 68-year-old female with a newly diagnosed, ratecontrolled atrial fibrillation (AF) and non-ischemic
cardiomyopathy with an ejection fraction of 2530% had an AICD and dual chamber pacemaker
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placed one month prior to presentation due to
ventricular tachycardia. Apixaban had been held
due to a hematoma at the pacemaker/defibrillator
implantation site.
She presented to the emergency room with
stroke-like symptoms. The computed tomography
angiography (CTA) revealed a left frontal ischemic
stroke from a middle cerebral artery
(MCA) branch occlusion. Neurology
decided to administer a systemic tissue
plasminogen activator (tPA) that improved
her neurological status. The patient denied
any symptoms related to her AF at that
time. On admission, the electrocardiogram
(EKG) showed rate-controlled AF. However,
interrogation of the AICD revealed her to
be in AF with a rapid ventricular rate (RVR),
ranging from 100 to 160 beats per minute
(bpm) around 50% of the time since the
implantation of the device. Neurology
cleared the patient to be restarted on
apixaban.
During her hospital stay, she developed
symptomatic AF with RVR. The
electrophysiologist adjusted her rate-control
medication. A cardioversion was scheduled but
not performed because the patient received two
inappropriate shocks for AF with RVR with
a rate of 244 bpm and then converted to
sinus rhythm. Her heart rate remained in
normal sinus rhythm on metoprolol and
amiodarone.

Apixaban was held while the RA and right ventricle
(RV) leads were revised. A repeat chest x-ray showed
successful revision of the leads (Figure 2). However,
the patient reverted to AF with RVR, which was
difficult to control. Amiodarone was discontinued
due to adverse effects, and digoxin was initiated
with plans for atrioventricular nodal (AVN) ablation.

FIGURE 1: AP Chest radiography indicating coiling leads
around AICD/Pacer (red arrow)

Previously, she had failed dofetilide due to
polymorphic ventricular tachycardia and
Torsade de Pointes (TdP) while taking a
selective serotonin reuptake inhibitor (SSRI).
Those medications were stopped at that
time.
Repeat interrogation of the AICD showed
right atrium (RA) lead malfunction, requiring
revision. A chest X-ray showed the leads
wrapped around the generator in the
pocket multiple times (Figure 1). She was
diagnosed with Twiddler’s syndrome based
on the clinical symptoms and imaging. She was then
scheduled for lead revision and AICD reprogramming.
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FIGURE 2: AP Chest radiography indicating leads revision
(green arrow)
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After inappropriate AICD shocks followed by revision
of the leads, she started to develop symptoms of
emotional distress, tearfulness, and insomnia. The
patient did report a history of anxiety. She was afraid
to move out of the bed because she did not want
to experience inappropriate shocks again. This fear
worsened when she noticed her heart rate increase
on the monitor with minimal exertion. Mental health
was consulted to evaluate the patient. She was
started on sertraline, which has a lesser risk for QT
prolongation.
After failing the rate-control medications and
considering her history of prolonged QT intervals
from antiarrhythmic medications, she underwent
AVN radiofrequency ablation instead of AF ablation
since she had a recent pacemaker pocket revision.
This led her to have rate-controlled AF with a
ventricular-paced rhythm. Her QT interval remained
stable on the sertraline. The patient was discharged
to inpatient rehabilitation on metoprolol and
digoxin for her rate-controlled AF and sertraline for
her acute stress and anxiety disorder.
DISCUSSION
Dofetilide is a class III antiarrhythmic agent approved
to maintain and achieve sinus rhythm in patients
with symptomatic AF and severe left ventricular
dysfunction. Dofetilide should be initiated in the
hospital under continuous telemetry with serial
EKGs and regular serum electrolyte monitoring.
In clinical trials, the risk of QT prolongation and
ventricular tachycardia (VT) occurred in < 3% of
patients.7 However, concomitant QT prolongation
medications are common in practice. In our case, the
patient was started on dofetilide with pre-existing
use of sertraline. The corrected QT interval (QTc)
before initiation of dofetilide was 492 milliseconds
(ms), and after initiation, the QTc was 539 ms
when she developed VT and TdP. This led to the
discontinuation of both medications. She later
developed another episode of VT induced by a
bradyarrhythmia; therefore, a decision was made for
AICD implantation.
In a retrospective cohort study, 114 patients involved
in studying dofetilide revealed that 28% of patients
used concomitant QT-prolonging medications. The
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most common medications included trazodone,
venlafaxine, and paroxetine. Dofetilide was
discontinued in 31% of those taking concomitant
QT-prolonging drugs versus 15% of patients who
were not taking concomitant QT-prolonging drugs
(P = 0.04). Reported discontinuation of dofetilide
with sertraline was 8% of patients and 25 % of
patients with trazodone. Concomitant usage of other
QT-prolonging drugs increased the risk of adverse
events by almost two-fold.7
As a result of the inappropriate shock from the
AICD secondary to Twiddler’s syndrome, our
patient developed acute stress disorder with some
symptoms of depression. She was more prone to
developing a new psychiatric disorder with her
previous history of generalized anxiety disorder
(GAD), a new diagnosis of stroke, and her recent
discontinuation of sertraline. Due to her symptoms
of anxiety and fear from receiving the inappropriate
shocks, new-onset insomnia, and tearful episodes,
sertraline was resumed. Dofetilide was considered
the highest contributing factor to her prolonged
QT previously. During her stay, her QTc interval
remained stable.
The SADHART (Sertraline Antidepressant HeartAttack Randomized Trial) studied the effect of
sertraline on the QT interval of patients who had an
acute MI or who were hospitalized with unstable
angina within 30 days of enrollment. There was
no statistically significant difference in QTc from
baseline after 16 weeks of treatment. Studies show
potentially clinically significant QT prolongation
only when sertraline is taken concomitantly with
other QT-prolonging medications. According to
post-marketing data, the risk of sertraline on QT
prolongation is rare.8
The patient did meet the Diagnostic and Statistical
Manual of Mental Disorders (DSM-V) criteria for
acute stress disorder. The abbreviated criteria of the
DSM-V for acute stress disorder defines it as exposure
to actual or threatened death with the presence of
nine or more defined symptoms from five categories.
The categories include intrusion, negative mood,
dissociation, avoidance, or arousal that starts
or worsens after the traumatic event. First-line
treatment for acute stress disorder is trauma-focused
cognitive behavioral therapy (CBT). However, with
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her underlying co-morbid psychiatric disorders such
as GAD and a new stroke diagnosis, resuming the
SSRI was decided to be more beneficial. In the FOCUS
(Effects Of Fluoxetine On Functional Outcomes After
Acute Stroke) trial, patients treated with an SSRI after
a stroke did not show a significant improvement in
their stroke-related disability, but the rate of newonset depression was less.9
CONCLUSION
Twiddler’s syndrome is treated surgically, but acute
stress disorder from inappropriate shocks requires
close attention to medical therapy, which can be
challenging. The risk of QT interval prolongation
is common with antiarrhythmic medication and
increases with the concomitant use of SSRIs. A risk
score by obtaining clinical risk factors to identify
patients with the highest risk of QTc interval
prolongation can be useful in guiding monitoring
and treatment decisions.10 The threshold should be
low for close monitoring of the patient when placed
on an SSRI in patients with proarrhythmic conditions.
Treating psychiatric disorders is a key element in
improving patient outcomes by reducing patient
stress and increasing patient adherence to treatment.
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